INDIANAPOLIS - As the prevalence of diabetes increases, Eli Lilly and Company is making strides to improve the availability of care to patients.
Lilly is increasing its insulin manufacturing capacity and adding two new insulin-cartridge-filling lines to the Indianapolis facility. Those cartridges can be used in insulin pens, which are growing in popularity.
Operations manager for filling, Lyle Fait, said the filling lines will pump 600 cartridge units a minute.
"With diabetes worldwide becoming almost epidemic in terms of the magnitude, this is the supply and demand that we are trying to meet in terms of keeping the global market supplied," Fait said.
Lilly is a global leader in the treatment of diabetes. The company introduced insulin as a treatment in 1923.
Officials said $400 million was being poured into the facilities, which will further Lilly’s pursuit of offering a full range of innovative options to diabetics.
National diabetes statistics show nearly 25.8 million people in the United States have diabetes. As many of seven million of those people are undiagnosed.
Train strikes car with 4 aboard on east side
A car with four people inside was struck by a train Saturday on the east side of Indianapolis.
8 students injured when Pike school buses crash
Multiple students were taken to the hospital after two Pike Township school buses collided on the city’s northwest side Friday evening.
WATCH: Volunteers create future haven for bees
A park in Brownsburg is creating a home for bees -- one hole at a time.
Two arrested in death of 1-year-old girl
Two people were arrested after a 1-year-old Greenfield girl died earlier this week.
Taxis complain competition with Uber isn't fair
Indiana tax drivers say Uber is taking their business, but doesn't have to face the same regulation they do.